Xtrackers Nordic Net Zero Pathway Paris Aligned UCITS ETF 1C (GBP) | XNZNRegistrer dig for at låse op for ratings |
Fondens performance | 30-04-2024 |
Vækst af 1.000 (DKK) | Avanceret graf |
Fond | - | - | - | - | 1,8 | |
+/-Kat | - | - | - | - | -3,6 | |
+/-Indeks | - | - | - | - | -6,1 | |
Kategori: Aktier - Norden | ||||||
Kategoribenchmark: Morningstar Nordic TME NR SEK |
Oversigt | ||
Closing Price 16-05-2024 | GBX 3091,50 | |
Kursændring 1 dag | -0,33% | |
Morningstar Kategori™ | Aktier - Norden | |
Omsætning | 0 | |
Børs | LONDON STOCK EXCHANGE, THE | |
ISIN | IE000HT7E0B1 | |
Markedsværdi i alt (mio.) 16-05-2024 | EUR 179,28 | |
Seneste TNA(mio.) 16-05-2024 | EUR 179,28 | |
Løbende omkostning 15-02-2024 | 0,15% | |
Investeringsstrategi | Passiv |
Investeringsmålsætning: Xtrackers Nordic Net Zero Pathway Paris Aligned UCITS ETF 1C (GBP) | XNZN |
The investment objective of the Fund is to track the performance before fees and expenses of an index which is designed to reflect the performance of companies of the Nordic countries that are selected and weighted with the aim of seeking alignment with EU Paris-aligned Benchmark (“EU PAB”) standards and certain net zero frameworks. |
Returns | |||||||||||||
|
Management | ||
Manager navn Startdato | ||
Ikke oplyst af foreningen 12-04-2023 | ||
Startdato 12-04-2023 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
Solactive ISS ESG Nor IU NZP NR EUR | Morningstar Nordic TME NR SEK |
Target Market | ||||||||||||||||||||
|
Formuefordeling Xtrackers Nordic Net Zero Pathway Paris Aligned UCITS ETF 1C (GBP) | XNZN | 30-04-2024 |
|
|
Top 5 placeringer | Sektor | % |
Novo Nordisk A/S Class B | Healthcare | 10,86 |
Zealand Pharma A/S | Healthcare | 2,70 |
Investor AB Class B | Finans | 2,65 |
Novonesis AS Class B | Materialer | 2,47 |
Pandora A/S | Cyklisk forbrug | 2,37 |
Øget Mindsket Ny siden sidste portefølje | ||
Xtrackers Nordic Net Zero Pathway Paris Aligned UCITS ETF 1C (GBP) | XNZN |